Figure 4.
Eed deletion impairs TEC proliferation, survival and differentiation. (a) Percentage of fetal and newborn EedCKO versus control TEC that incorporate BrdU after injection into pregnant or newborn mice. (b) qRT-PCR analysis of Cdkn2a expression in E17.5 TEC isolated by FACS sorting. Expression in EedCKO TEC is normalized to control TEC. Each sample was analyzed in triplicate and the experiment was repeated twice. (c) Percentage of cleaved caspase 3 (CC3) positive Foxn1+ TEC in P0 EedCKO and control thymi. The frequency of apoptotic TEC was determined by counting the total number of Foxn1+ TEC that were positive for CC3 on each of 3 different sections/thymus. Results shown are from three independent experiments. (d) Frozen sections from P0 thymi were stained for K8 (green), K5 (red) and K14 (blue). White arrows indicate K8+K5+K14− TEC near the CMJ; this subset is widely distributed in controls, but sparse in mutant thymi. Note also the smaller medullary regions identified by K8−K5+K14+ TEC in EedCKO thymi. White bar indicates scale (250 μm). (e) Representative FACS plots of EpCAM+ CD45− TEC from P0 mice showing the distribution of UEA+Ly51− mTEC and UEA− Ly51+ cTEC subsets in control and EedCKO thymi. (f) Representative FACS plots showing expansion of the MHCIIlo TEC subset in P0 EedCKO thymi. (g) Bar graph showing percentage (mean ± SD) of cTEC and mTEC subsets in control and EedCKO thymi. (h) Bar graph showing number (mean ± SD) of cTEC and mTEC in control and EedCKO thymi. Significance was calculated using an unpaired t test corrected for multiple comparisons using the Holm-Sidak method (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).